Form 4: Medicine Man Technologies Director Acquires Shares as Part of Board Service Compensation

Marc R. Rubin, a director at Medicine Man Technologies, acquired 32,012 shares of common stock as compensation for his board service.

Summary

• On March 29, 2024, Marc R. Rubin, a director of Medicine Man Technologies, Inc., acquired 32,012 shares of common stock.
• The shares were granted as compensation for his service on the board of directors.
• The aggregate value of the shares was $26,250, based on the closing price of the common stock on the OTCQX Best Market on March 28, 2024.
• Following the transaction, Rubin directly owns 177,468 shares of Medicine Man Technologies, Inc.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The sentiment is moderately positive as it reflects director alignment with shareholder interests through stock ownership.

Positives

• The acquisition of shares by a director demonstrates alignment of interests with shareholders.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It reflects compensation practices for board members.

Comparison to Industry Standards

• Director compensation in the form of stock grants is a common practice among publicly traded companies, particularly smaller ones, to align director interests with shareholder value.
• The size of the grant, $26,250, would need to be compared to peer companies of similar size and industry to determine if it is within the typical range.
• Companies like Canopy Growth Corporation, Aurora Cannabis, and Tilray, although much larger, also utilize stock-based compensation for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Medicine Man Technologies, SHWZ, Form 4, Director, Share Acquisition, Marc R. Rubin, Board Service, Compensation, OTCQX, Beneficial Ownership